phentermine vs glp 1 Ozempic Phentermine vs GLP-1 Medications: Which

Alhomoud IS, Talasaz AH, Chandrasekaran P, Brown R, Mehta A, Dixon DL

In 2019, the REWIND trial found that in the 9901 patients with T2DM with and without previous CVD randomly assigned to a once-weekly 1.5 mg dulaglutide injection or placebo (median follow-up 5.4 years), three-point MACE occurred in 594 patients receiving dulaglutide (12.0%) and in 663 patients (13.4%) in the placebo group, which included a significant decrease in the rate of non-fatal stroke (Gerstein et al

Available from: Kunz M, Gama CS, Andreazza AC, Salvador M, Ceresr KM, Gomes FA, et al

Diabetes Care 2018;41:2669-701

Hospitals & Clinics 13.2.2

Glucagon-like peptide1 analogues for type 2 diabetes mellitus